tert-butyl 3-oxa-2-thia-1-azaspiro[4.4]nonane-1-carboxylate 2,2-dioxide

Catalog No. :
ACLVMI234
CAS No. :
2306264-26-4
Molecular Formula :
C11H19NO5S
Molecular Weight :
277.34

IUPAC Name:tert-butyl 3-oxa-2-thia-1-azaspiro[4.4]nonane-1-carboxylate 2,2-dioxide

tert-butyl 3-oxa-2-thia-1-azaspiro[4.4]nonane-1-carboxylate 2,2-dioxide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$239.00Login to see priceInquiryInquiry
250mg98%$319.00Login to see priceInquiryInquiry
1g98%$665.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-butyl 3-oxa-2-thia-1-azaspiro[4.4]nonane-1-carboxylate 2,2-dioxide
IUPAC Nametert-butyl 3-oxa-2-thia-1-azaspiro[4.4]nonane-1-carboxylate 2,2-dioxide
MDL No.MFCD31743878
Molecular FormulaC11H19NO5S
Molecular Weight277.34
SMILESCC(C)(C)OC(=O)N1C2(CCCC2)COS1(=O)=O
InChI KeyCFRQOGVGOBYOJM-UHFFFAOYSA-N
Synonym3-Oxa-2-thia-1-azaspiro[4.4]nonane 2,2-dioxide, N-BOC protected;tert-butyl 2,2-dioxo-3-oxa-2λ?-thia-1-azaspiro[4.4]nonane-1-carboxylate;3-Oxa-2-thia-1-azaspiro[4.4]nonane-1-carboxylic acid, 1,1-dimethylethyl ester, 2,2-dioxide
CAS No.2306264-26-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACLVMI234 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLVMI234 route product structure diagram
    ACLVMI2342306264-26-4
Inquiry

2. ACLVMI234 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLVMI234 route product structure diagram
    ACLVMI2342306264-26-4
Inquiry

Comments (0)